# Cardiosolutions

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cardiosolutions

- Industry: Medical Devices & Equipment
- Headquarters: West Bridgewater, US
- Website: www.cardiosolutionsinc.com
- Total disclosed funding: $7M
- Latest round: Series A (Sep 24, 2007)
- Investors on record: 1

## About

Cardiosolutions, Inc. specializes in innovative technology solutions, enhancing efficiency and productivity in various industries through its advanced software applications.Founded in 2006 in West Bridgewater, US, Cardiosolutions, Inc. focuses on technology solutions for healthcare, finance, and manufacturing sectors. The company was founded by Perrin Peacock, who has a history of entrepreneurship. The firm has raised USD 8.00 mn in financing from Sorin Group as of July 2012.Cardiosolutions, Inc. specializes in delivering innovative technology solutions addressing efficiency and productivity challenges across multiple industries. Its main products include software applications designed for project management, data analytics, and customer relationship management, which streamline operations and enhance collaboration. The software has gained traction in sectors such as healthcare, finance, and manufacturing since its initial release in 2018, serving mid-sized to large enterprises across North America and Europe.Revenue is generated through a mix of subscription-based services and direct software licenses sales. Their transaction structure primarily follows a B2B model, with clients engaging in annual or multi-year subscription agreements. Pricing for flagship products, such as the project management application, is based on user numbers and selected features, allowing for tailored solutions. Partnerships with industry leaders enhance their market reach and provide integrated solutions, contributing to long-term revenue growth.Cardiosolutions, Inc. plans to utilize the USD 8.00 mn raised in July 2012 to support the development of upcoming software products and to expand into new markets. The company is focusing on enhancing its product offerings and aims to enter the Asian market by 2024, targeting regions with increasing demand for advanced technology solutions.

## Funding rounds

- Series A, Sep 24, 2007, $7M — BioVentures Investors

## Investors

- BioVentures Investors (https://capitalatlas.ai/funds/bioventures-investors) — Series A